Dambisya Y M, Chan K, Wong C L
Department of Pharmacology, Faculty of Medicine, Chinese University of Hong Kong, Shatin, New Territories.
J Pharm Pharmacol. 1992 Aug;44(8):687-90. doi: 10.1111/j.2042-7158.1992.tb05497.x.
Brain and plasma levels of morphine and codeine were determined by an assay method involving solid-phase extraction and ion-pair reversed phase HPLC. Detection was by a variable wavelength UV-detector (for codeine) and an amperometric electro-chemical detector (for morphine) coupled in series. Ephedrine or phenylpropanolamine pretreatment did not interfere with the plasma disposition of morphine, evidenced by overlapping plasma concentration-time profiles. Brain opioid levels were equally unaffected by sympathomimetic pretreatment. The relative ratios of brain to plasma concentrations at the time corresponding to the respective peak anti-nociceptive activity for morphine and codeine revealed no significant differences. It is concluded that single doses of ephedrine and phenylpropanolamine do not affect the disposition of morphine and codeine in mice.
采用固相萃取和离子对反相高效液相色谱法测定了脑和血浆中吗啡及可待因的含量。检测采用串联的可变波长紫外检测器(用于可待因)和安培电化学检测器(用于吗啡)。麻黄碱或苯丙醇胺预处理并未干扰吗啡的血浆处置,这可通过重叠的血浆浓度-时间曲线得以证明。拟交感神经药预处理对脑阿片类物质水平同样没有影响。在对应吗啡和可待因各自最大抗伤害感受活性的时间点,脑与血浆浓度的相对比值并无显著差异。得出的结论是,单剂量的麻黄碱和苯丙醇胺不影响吗啡和可待因在小鼠体内的处置。